Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
THEMIS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMPDL3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STX12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XKR8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM76A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EYA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFI6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AHDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on